Surface Proteomics Reveals CD72 as a Target for In Vitro –Evolved Nanobody-Based CAR-T Cells in KMT2A/MLL1 -Rearranged B-ALL is a research paper published in Cancer Discovery (2021). On theSindex it has a DataRank of 0.654. It has been cited 77 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.654
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: DP2 OD022552
National Institutes of Health
Grant: K08 CA184116
National Institutes of Health
Grant: K08 CA230188
National Institutes of Health
Grant: P30 CA082103
NIGMS NIH HHS
Grant: DP2 GM123500
FWCI
4.94
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of An amino acid transporter subunit as an antibody–drug conjugate target in colorectal cancer
Additional file 1 of An amino acid transporter subunit as an antibody–drug conjugate target in colorectal cancer
Additional file 2 of An amino acid transporter subunit as an antibody–drug conjugate target in colorectal cancer
Additional file 2 of An amino acid transporter subunit as an antibody–drug conjugate target in colorectal cancer
Additional file 3 of An amino acid transporter subunit as an antibody–drug conjugate target in colorectal cancer
Additional file 3 of An amino acid transporter subunit as an antibody–drug conjugate target in colorectal cancer
Additional file 4 of An amino acid transporter subunit as an antibody–drug conjugate target in colorectal cancer
Additional file 4 of An amino acid transporter subunit as an antibody–drug conjugate target in colorectal cancer
Additional file 1 of Decoding of the surfaceome and endocytome in primary glioblastoma cells identifies potential target antigens in the hypoxic tumor niche
Additional file 1 of Decoding of the surfaceome and endocytome in primary glioblastoma cells identifies potential target antigens in the hypoxic tumor niche
Additional file 3 of Decoding of the surfaceome and endocytome in primary glioblastoma cells identifies potential target antigens in the hypoxic tumor niche
Additional file 3 of Decoding of the surfaceome and endocytome in primary glioblastoma cells identifies potential target antigens in the hypoxic tumor niche
Additional file 2 of Decoding of the surfaceome and endocytome in primary glioblastoma cells identifies potential target antigens in the hypoxic tumor niche
Additional file 2 of Decoding of the surfaceome and endocytome in primary glioblastoma cells identifies potential target antigens in the hypoxic tumor niche
Additional file 4 of Decoding of the surfaceome and endocytome in primary glioblastoma cells identifies potential target antigens in the hypoxic tumor niche
Additional file 4 of Decoding of the surfaceome and endocytome in primary glioblastoma cells identifies potential target antigens in the hypoxic tumor niche